Leon Chen

Leon is Founding Partner and CEO of 6 Dimensions Capital, a leading biotech venture capital firm with over $1.5 billion in AUM. Leon has over 20 years of experience in the life sciences industry in China and the U.S. as a venture capitalist, senior management executive, entrepreneur, and scientific inventor. He is a member of the Expert Review Panel for the Chinese Central Government HR’s 1000 Talent Project, and an adviser to BioBAY of Suzhou Industry Park.

As a venture capital investor, his past affiliations include Fidelity Growth Partners-Asia (Partner) and BioVeda China (Managing Partner). Representative Investments include CITIC Pharmaceutical (Board Director, Acting CFO), Cathay Industrial Biotechnology (Board Director), Hile Biopharma (Board Director), Hua Medicine (Shanghai) (Board Director), Innovent Biologics Ltd (Chairman), Adagene (Board Director) and MDDF (Board Director).

As a management consultant, his past affiliations include McKinsey & Company (Brussels), Ernst & Young (Palo Alto) and Life Science Strategic Consulting (Managing Partner, San Francisco Bay Area). As a Ph.D. scientist, he worked with Schering Plough (New Jersey), and is a key member of the discovery team of Zytia / Vytorin – a multi-billion drug. Leon was a Post-Doc at MIT and received his Ph.D. (with top honors) from the University of Louvain, Louvain-La-Neuve and his B.S. from Peking University. Leon holds 6 issued US Patents, and is co-author of the 14th and 15th Ernst & Young Biotechnology Annual Report.